Enanta Pharmaceuticals
ENTA
#7342
Rank
NZ$0.77 B
Marketcap
NZ$26.89
Share price
-3.08%
Change (1 day)
138.38%
Change (1 year)

EPS for Enanta Pharmaceuticals (ENTA)

EPS in 2025 (TTM): NZ-$6.63

According to Enanta Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$6.56. In 2024 the company made an earnings per share (EPS) of NZ-$8.47.

EPS history for Enanta Pharmaceuticals from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$6.63-21.79%
2024NZ-$8.47
2021NZ-$8.5272.92%
2020NZ-$4.93-267.44%
2019NZ$2.94-61.35%
2018NZ$7.62147.22%
2017NZ$3.08-460%
2016NZ-$0.86-114.88%
2015NZ$5.75-23.81%
2014NZ$7.55-244.12%
2013NZ-$5.24

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
AbbVie
ABBV
NZ$2.31-135.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$17.87-372.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$24.53-474.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.00-298.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.08-177.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.60-292.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland